Detectable Digoxin Concentrations in 3 Patients with Ramps Misadventure
Joshua Trebach1, Vincent Calleo2, Sara Akbar3
1Division of Medical Toxicology, Ronald O. Perelman Department of Emergency Medicine, NYU Grossman School of Medicine, New York, New York; New York City Poison Control Center, Department of Health and Mental Hygiene, New York, New York.
Foraging for edible Allium tricoccum (ramps) can lead to accidental ingestion of toxic plants like Lily of the Valley or False Hellebore. These mimics can cause symptoms and detectable digoxin concentrations, highlighting a critical patient safety concern.
Area of Science:
- Toxicology
- Botany
- Emergency Medicine
Background:
- Allium tricoccum (ramps) is a wild edible plant with a distinct garlic-onion flavor.
- Misidentification of ramps with toxic look-alikes, such as Convallaria majalis (Lily of the Valley) and Veratrum species (False Hellebore), poses a significant risk.
Observation:
- Three adult patients presented with hypotension and bradycardia after consuming a plant mistaken for ramps.
- Detected digoxin concentrations in patients ranged from 0.08 to 0.13 ng/mL.
- Plant analysis confirmed the presence of cyclopamine, an alkaloid found in Veratrum species.
Findings:
- Convallaria majalis contains convallatoxin, a cardiac glycoside that can elevate digoxin levels.
- Veratrum species contain alkaloids like veratridine, which can cause false positives in digoxin assays.
- Ingestion of these toxic plants can mimic cardiac glycoside toxicity.
Implications:
- Clinicians should consider toxic plant ingestion, specifically Convallaria majalis or Veratrum species, in patients presenting with bradycardia, gastrointestinal issues, and elevated digoxin levels after foraging.
- Accurate plant identification is crucial to prevent severe toxicity and misdiagnosis in foraging-related incidents.
- Awareness of these plant mimics is essential for emergency departments managing potential poisonings.
More Related Videos
14:03High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers
Published on: March 24, 2023
16:40A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Dysrhythmias V: Evaluating Dysrhythmias
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Depolarizing Blockers: Pharmocokinetics
